• Aucun résultat trouvé

Bone marrow transplantation

Donor lymphocyte infusion for late relapse followed by kidney transplantation for end-stage renal failure after allogeneic bone marrow transplantation for chronic myeloid leukemia.

Donor lymphocyte infusion for late relapse followed by kidney transplantation for end-stage renal failure after allogeneic bone marrow transplantation for chronic myeloid leukemia.

... Renal transplantation without im- munosuppression in a host with tolerance induced by allogeneic bone marrow ...transplantation. Transplantation 1994; 58: 1420 ...

2

Antithymocyte globulin before allogeneic stem cell transplantation for progressive myelodysplastic syndrome : a study from the French Society of Bone Marrow Transplantation and Cellular Therapy

Antithymocyte globulin before allogeneic stem cell transplantation for progressive myelodysplastic syndrome : a study from the French Society of Bone Marrow Transplantation and Cellular Therapy

... Participating centers verified the data recorded for each patient in the French Bone Marrow Transplantation Registry and provided additional in- formation. Quality of the data and HLA matching were ...

9

Transplant Outcomes for Secondary Acute Myeloid Leukemia: Acute Leukemia Working Party of the European Society for Blood and Bone Marrow Transplantation Study.

Transplant Outcomes for Secondary Acute Myeloid Leukemia: Acute Leukemia Working Party of the European Society for Blood and Bone Marrow Transplantation Study.

... cell transplantation (HCT); thus, this large systemic analysis of the European Society for Blood and Bone Marrow Transplantation registry was ...

9

Allogeneic peripheral blood stem cell transplantation with anti-thymocyte globulin versus allogeneic bone marrow transplantation without anti-thymocyte globulin.

Allogeneic peripheral blood stem cell transplantation with anti-thymocyte globulin versus allogeneic bone marrow transplantation without anti-thymocyte globulin.

... Cell Transplantation Unit, Helsinki, Finland; 8 University Hospital Eppendorf, Bone Marrow Transplantation Center, Hamburg, Germany; 9 Institute of Clinical Medicine, Vilnius University and ...

9

CD4(+)CD25(+) regulatory T lymphocytes in bone marrow transplantation.

CD4(+)CD25(+) regulatory T lymphocytes in bone marrow transplantation.

... Bone marrow transplantation is extensively used to correct hereditary defects (such as primary immunodeficiencies, metabolic diseases or hemoglobinopathies), hematologic malignancies (such as acute ...

17

Retrospective comparison of CD34-selected allogeneic peripheral blood stem cell transplantation followed by CD8-depleted donor lymphocyte infusions with unmanipulated bone marrow transplantation.

Retrospective comparison of CD34-selected allogeneic peripheral blood stem cell transplantation followed by CD8-depleted donor lymphocyte infusions with unmanipulated bone marrow transplantation.

... 14. Schaap N, Schattenberg A, Bar B, Preijers F, van de Wiel van Kemenade, De Witte T: Induction of graft- versus-leukemia to prevent relapse after partially lymphocyte-depleted allogeneic bone marrow ...

21

Aggressive skin cancers in patients who experienced chronic GvHD after allogeneic bone marrow transplantation

Aggressive skin cancers in patients who experienced chronic GvHD after allogeneic bone marrow transplantation

... after bone marrow ...after transplantation and even after resolution of ...their marrow-transplanted patients examined annually by a dermatologist throughout ...

2

Reduced intensity and non-myeloablative allogenic stem cell transplantation from alternative HLA-mismatched donors for Hodgkin's lymphoma: a study by the French Society of Bone Marrow Transplantation and Cellular Therapy

Reduced intensity and non-myeloablative allogenic stem cell transplantation from alternative HLA-mismatched donors for Hodgkin's lymphoma: a study by the French Society of Bone Marrow Transplantation and Cellular Therapy

... extend transplantation for patients with lymphoma who lack an HLA matched ...donor. Bone Marrow Transplant 2015; 50: ...of Bone Marrow Transplantation and Cellular Therapy ...

8

Bronchiolitis obliterans organizing pneumonia and ulcerative colitis after allogeneic bone marrow transplantation.

Bronchiolitis obliterans organizing pneumonia and ulcerative colitis after allogeneic bone marrow transplantation.

... allogeneic bone marrow transplantation; autoimmune diseases; ulcerative colitis; BOOP; adoptive autoimmunity Bronchiolitis obliterans organizing pneumonia (BOOP) is a rare cause of diffuse ...

4

Allogeneic Stem Cell Transplantation in Therapy-Related Myelodysplasia after Autologous Transplantation for Lymphoma: A Retrospective Study of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy

Allogeneic Stem Cell Transplantation in Therapy-Related Myelodysplasia after Autologous Transplantation for Lymphoma: A Retrospective Study of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy

... Acute graft-versus-host disease (GVHD) was described according to the criteria of the International Bone Marrow Transplantation Registry [18] . For the analysis of cytomegalovirus (CMV) serostatus, ...

9

The belgian experience in unrelated donor bone marrow transplantation: identification of center experience as an important prognostic factor.

The belgian experience in unrelated donor bone marrow transplantation: identification of center experience as an important prognostic factor.

... words: bone marrow transplantation, unrelated donor, GVHD A llogeneic bone marrow transplantation (allo- BMT) has become the treatment of choice for a variety of hematologic ...

6

Better outcome with haploidentical over HLA-matched related donors in patients with Hodgkin's lymphoma undergoing allogeneic haematopoietic cell transplantation - A study by the Francophone Society of Bone Marrow Transplantation and Cellular Therapy

Better outcome with haploidentical over HLA-matched related donors in patients with Hodgkin's lymphoma undergoing allogeneic haematopoietic cell transplantation - A study by the Francophone Society of Bone Marrow Transplantation and Cellular Therapy

... Abstract The question of the best donor type between haploidentical (HAPLO) and matched-related donors (MRD) for patients with advanced HL receiving an allogeneic hematopoietic cell transplantation (allo-HCT) is ...

10

Long lasting IgG subclass and antibacterial polysaccharide antibody deficiency after allogeneic bone marrow transplantation.

Long lasting IgG subclass and antibacterial polysaccharide antibody deficiency after allogeneic bone marrow transplantation.

... The analysis of subclass levels in the last studied samples showed that long-term subclass deficiencies were observed predominantly in infected patients (only one noninfected patient had[r] ...

9

Allogeneic peripheral blood stem cell transplantation with anti-thymocyte globulin versus allogeneic bone marrow transplantation without anti-thymocyte globulin

Allogeneic peripheral blood stem cell transplantation with anti-thymocyte globulin versus allogeneic bone marrow transplantation without anti-thymocyte globulin

... other transplantation outcomes of acute myeloid leukemia (AML) patients given bone marrow (BM) with- out anti-thymocyte globulin (ATG) versus peripheral blood stem cells (PBSC) with ATG after ...

10

Circulating erythropoietin levels after bone marrow transplantation: inappropriate response to anemia in allogeneic transplants.

Circulating erythropoietin levels after bone marrow transplantation: inappropriate response to anemia in allogeneic transplants.

... In the present study, we investigated whether defective erythropoietin (Epo) production could contribute to de- layed erythropoietic engraftment after BMT, using sensi- [r] ...

6

A Cellular Taxonomy of the Bone Marrow Stroma in Homeostasis and Leukemia

A Cellular Taxonomy of the Bone Marrow Stroma in Homeostasis and Leukemia

... into bone, fat and cartilage in vitro (Kfoury and Scadden, ...including bone marrow derived endothelial cells (BMECs) and MSC-descendent osteolineage cells (OLCs), also function as niche ...and ...

38

Induction of antigen-specific tolerance to bone marrow allografts with CD4+CD25+ T lymphocytes.

Induction of antigen-specific tolerance to bone marrow allografts with CD4+CD25+ T lymphocytes.

... allogeneic bone-marrow We have adapted our previously described mouse model for bone-marrow transplantation in which B6 (H-2 b ) hosts are lethally irradiated and reconstituted with a ...

27

MRI quantification of diffusion and perfusion in bone marrow by intravoxel incoherent motion (IVIM) and non-negative least square (NNLS) analysis.: IVIM and NNLS in bone marrow

MRI quantification of diffusion and perfusion in bone marrow by intravoxel incoherent motion (IVIM) and non-negative least square (NNLS) analysis.: IVIM and NNLS in bone marrow

... Discussion In the current study, the feasibility of measuring the water ADC and perfusion in vertebral bone marrow was investigated on a 1.5 T clinical scanner with the IVIM approach, in combination with ...

25

Bone marrow-derived mesenchymal cells and MMP13 contribute to experimental choroidal neovascularization.

Bone marrow-derived mesenchymal cells and MMP13 contribute to experimental choroidal neovascularization.

... An involvement of MMPs in the progression of retinal and choroidal neovascularization is supported by both experimental and clinical data. A mutation of Timp-­‐3 gene (tissue inhibitor of metalloproteinase-­‐3) is the ...

19

The effects of dietary fatty acids on bone, hematopoietic marrow and marrow adipose tissue in a murine model of senile osteoporosis

The effects of dietary fatty acids on bone, hematopoietic marrow and marrow adipose tissue in a murine model of senile osteoporosis

... muscle, bone marrow and viscera) [6, 7, 11, 12] leads to a pathological state where adipocytes lose the ability to metabolize triglycerides, respond to hormones ...the marrow milieu and ...

11

Show all 1096 documents...

Sujets connexes